Comparison of IL-10 levels in chronic venous insufficiency ulcers and autologous donor tissue

被引:16
作者
Lundberg, JE [1 ]
Roth, TP [1 ]
Dunn, RM [1 ]
Doyle, JW [1 ]
机构
[1] Univ Massachusetts, Med Ctr, Div Plast Surg, Worcester, MA 01655 USA
关键词
cytokines; wound healing; venous ulcers; inflammation;
D O I
10.1007/s004030050371
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
In previous immunohistochemical studies, chronic venous insufficiency (CVI) ulcers have been shown to display positive staining for interleukin-10 (IL-10), while other wounds (including autologous donor wound tissue) show a reduced staining level. IL-10 inhibits the synthesis of many proinflammatory cytokines, while also inhibiting antigen presentation by antigen-presenting cells. It is possible that abnormally high amounts of IL-10 in chronic wounds may be related to the failure of these wounds to progress to final wound healing. The purpose of this study was to quantify the levels of IL-10 in CVI ulcers and autologous donor tissue using Western blotting. Extracts were prepared from frozen wound tissue samples and equal amounts of protein were concentrated by immuneprecipitation for Western blot analysis. Densitometric analysis was performed on nonsaturated chemilumigraphs and normalized to an IL-10 standard run on each gel. The quantity of IL-10 in CVI ulcers was found to be 490 % of the quantity in autologous donor tissue. This study provides confirmatory quantitative data which supports previous immunohistochemical findings showing elevated levels of IL-10 in CVI ulcers.
引用
收藏
页码:669 / 673
页数:5
相关论文
共 24 条
[1]
STRATEGIES OF ANTICYTOKINE MONOCLONAL-ANTIBODY DEVELOPMENT - IMMUNOASSAY OF IL-10 AND IL-5 IN CLINICAL-SAMPLES [J].
ABRAMS, JS ;
RONCAROLO, MG ;
YSSEL, H ;
ANDERSSON, U ;
GLEICH, GJ ;
SILVER, JE .
IMMUNOLOGICAL REVIEWS, 1992, 127 :5-24
[2]
BARBUL A, 1990, J TRAUMA, V30, pS97
[3]
Calvin M, 1998, WOUNDS, V10, P12
[4]
B7-1 EXPRESSION OF LANGERHANS CELLS IS UP-REGULATED BY PROINFLAMMATORY CYTOKINES, AND IS DOWN-REGULATED BY INTERFERON-GAMMA OR BY INTERLEUKIN-10 [J].
CHANG, CH ;
FURUE, M ;
TAMAKI, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (02) :394-398
[5]
Cheatle T R, 1991, Eur J Vasc Surg, V5, P115, DOI 10.1016/S0950-821X(05)80674-7
[6]
DACOSTA RM, 1994, LANCET, V344, P481
[7]
Dale J J, 1983, Health Bull (Edinb), V41, P310
[8]
DING L, 1993, J IMMUNOL, V151, P1224
[9]
ENK AH, 1993, J IMMUNOL, V151, P2390
[10]
A THERAPEUTIC APPROACH TO VENOUS ULCERS [J].
FALANGA, V ;
EAGLSTEIN, WH .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1986, 14 (05) :777-784